Sign in
4

Changes in Ownership

Ernexa Therapeutics Inc. Filed Acc 0001493152-20-005355

CEO acquired 11,654 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Wolff Allen · CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-03-27 Grant or award : show line 1 in the form +1,074 $1.48 $1,590 140,642 D
2020-03-27 Grant or award : show line 2 in the form +10,580 $1.48 $15,658 151,222 D
Loading xslF345X03/ownership.xml…